KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $222.0 million.

  • Abbott Laboratories' Short-term Investments fell 347.83% to $222.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $222.0 million, marking a year-over-year decrease of 347.83%. This contributed to the annual value of $351.0 million for FY2024, which is 835.51% down from last year.
  • Latest data reveals that Abbott Laboratories reported Short-term Investments of $222.0 million as of Q3 2025, which was down 347.83% from $331.0 million recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Short-term Investments registered a high of $483.0 million during Q1 2022, and its lowest value of $222.0 million during Q3 2025.
  • In the last 5 years, Abbott Laboratories' Short-term Investments had a median value of $331.0 million in 2025 and averaged $333.6 million.
  • As far as peak fluctuations go, Abbott Laboratories' Short-term Investments soared by 5537.85% in 2021, and later plummeted by 3600.0% in 2022.
  • Over the past 5 years, Abbott Laboratories' Short-term Investments (Quarter) stood at $450.0 million in 2021, then plummeted by 36.0% to $288.0 million in 2022, then soared by 32.99% to $383.0 million in 2023, then dropped by 8.36% to $351.0 million in 2024, then tumbled by 36.75% to $222.0 million in 2025.
  • Its Short-term Investments was $222.0 million in Q3 2025, compared to $331.0 million in Q2 2025 and $312.0 million in Q1 2025.